查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598546

全球嬰兒臨床營養市場 – 全球產業分析、規模、佔有率、成長、趨勢、預測 (2031)

Infant Clinical Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031
出版日期: | 出版商: Fairfield Market Research | 英文 159 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

在 2024 年至 2031 年的預測期內，全球嬰兒臨床營養市場規模預計將以 6.1% 的複合年增長率擴大。在出生率上升、消費者意識提高和營養科學進步的推動下，2024 年市場價值預計將達到 275.3 億美元，預計到 2031 年將達到 416.8 億美元。

由於人們對嬰兒健康需求的認識不斷增強以及早產的普遍存在，對嬰兒臨床營養產品的需求正在上升。根據世界衛生組織 (WHO) 統計，每年有超過 1500 萬早產兒出生，凸顯了對營養補充劑的需求。因此，產品配方的創新，包括牛奶、大豆、有機和益生菌/益生元產品，正在推動市場成長。

世界出生率不斷上升，特別是在發展中國家，這促使對嬰兒營養產品的需求增加。各國政府和醫療機構正積極努力改善早產的預後，進一步提振市場。

本報告考察了全球嬰兒臨床營養市場，並提供了市場概況，包括按產品類型、給藥途徑、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • 杵分析

第 3 章2019-2031 年全球嬰兒臨床營養市場展望

  • 2019-2031 年全球嬰兒臨床營養市場展望（按產品類型、價值（十億美元））
  • 2019-2031 年全球嬰兒臨床營養市場展望（按給藥途徑）、價值（十億美元）
  • 2019-2031 年全球嬰兒臨床營養市場展望（按地區、價值（十億美元））

第 4 章 2019-2031 年北美嬰兒臨床營養市場展望

第 5 章歐洲嬰兒臨床營養市場展望，2019-2031

第六章亞太地區嬰兒臨床營養市場展望，2019-2031

第 7 章拉丁美洲嬰兒臨床營養市場展望，2019-2031

第 8 章中東與非洲嬰兒臨床營養市場展望，2019-2031 年

第九章競爭態勢

  • 依產品類型和給藥途徑劃分的熱圖
  • 2024 年公司市佔率分析
  • 競爭對手儀表板
  • 公司簡介
    • Abbott Laboratories
    • Baxter International Inc.
    • Nestle S.A.
    • Danone
    • Meiji Holdings Co., Ltd.,
    • Fresenius SE & Co. KGaA
    • Reckitt Benckiser Group Plc
    • Perrigo Co. Plc
    • Ingredion Inc.
    • Solace Nutrition

第 10 章附錄

簡介目錄

The global infant clinical nutrition market is projected to expand at a CAGR of 6.1% during the forecast period from 2024 to 2031. Valued at US$ 27.53 billion in 2024, the market is expected to reach US$ 41.68 billion by 2031, fueled by increasing birth rates, rising consumer awareness, and advancements in nutritional science.

The demand for infant clinical nutrition products is on the rise due to growing awareness of infant health needs and the prevalence of premature births. According to the World Health Organization (WHO), more than 15 million preterm babies are born annually, emphasizing the need for nutrition-rich supplements. As a result, innovations in product formulations, including milk-based, soy-based, organic, and probiotic/prebiotic products, are driving market growth.

Key Market Drivers

1.Increasing Birth Rates and Premature Births:

  • Global birth rates are rising, particularly in developing nations, creating an increased demand for infant nutritional products.
  • Governments and healthcare organizations are actively working to improve the outcomes of preterm births, further boosting the market.

2.Consumer Awareness and Lifestyle Changes:

  • With rising female labor force participation, dual-income households are increasingly investing in premium nutritional products for their infants.
  • Growing awareness about infant health needs and nutritional supplements is driving the demand for high-quality products.

3.Demand for Premium Products:

  • Parents are willing to spend more on premium-quality infant nutrition products due to improved purchasing power and heightened health consciousness.

4.Technological Advancements:

  • Continuous research in biotechnology is enabling manufacturers to develop specialized products that cater to diverse nutritional needs, improving metabolic and developmental outcomes.

Opportunities in the Market

1.Innovation in Product Development:

  • Manufacturers are focusing on developing advanced formulations, including organic and probiotic-based products, to meet specific infant needs.
  • Incorporation of cutting-edge technologies and neonatal care research is paving the way for more effective nutritional solutions.

2.Geographical Expansion:

  • Emerging markets in South Asia, East Asia, and Africa are becoming key areas of growth due to rising birth rates and increased awareness of infant health.

3.Strategic Investments:

  • Multinational players are heavily investing in research, branding, and supply chain optimization to strengthen their market position.

Challenges Facing the Market

Stringent regulations from authorities such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) impose strict quality standards. Manufacturers must comply with nutrient specifications and labeling requirements, often resulting in prolonged approval procedures and higher production costs.

Regional Insights

North America:

  • North America is a prominent region in the infant clinical nutrition market, driven by advancements in food nutrition.
  • The increasing adoption of clean-label trends significantly contributes to the region's market growth.

Europe:

  • Europe plays a key role in the market, with a growing preference for premium-quality infant nutrition products.
  • Capital investments in the food sector and rising consumer awareness about nutritional supplements are major growth factors.

Asia-Pacific:

  • Asia-Pacific is emerging as the fastest-growing region in the infant clinical nutrition market.
  • Population growth and improvements in healthcare infrastructure are key drivers boosting market expansion in this region.

Competitive Analysis

The infant clinical nutrition market is highly competitive, with multinational players dominating the landscape. Companies are focusing on R&D, branding, and innovative product launches to attract new customers and retain existing ones.

Key Players Include:

  • Abbott Laboratories
  • Baxter International
  • Nestle S.A.
  • Danone
  • Meiji Holdings Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Reckitt Benckiser Group Plc
  • Perrigo Co. Plc
  • Ingredion Inc.
  • Solace Nutrition

These companies are leveraging advanced technologies and efficient production processes to enhance product offerings and meet rising consumer demands.

Infant Clinical Nutrition Market Segmentation

1.By Product Type:

  • Milk-Based
  • Soy-Based
  • Organic
  • Probiotic/Prebiotic

2.By Route of Administration:

  • Oral Administration
  • Enteral Administration
  • Intravenous Administration

3.By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Infant Clinical Nutrition Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 3.1. Global Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Milk-Based
      • 3.1.1.2. Soy-Based
      • 3.1.1.3. Organic
      • 3.1.1.4. Probiotic/Prebiotic
  • 3.2. Global Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Oral administration
      • 3.2.1.2. Enteral administration
      • 3.2.1.3. Intravenous administration
  • 3.3. Global Infant Clinical Nutrition Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 4.1. North America Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Milk-Based
      • 4.1.1.2. Soy-Based
      • 4.1.1.3. Organic
      • 4.1.1.4. Probiotic/Prebiotic
  • 4.2. North America Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Oral administration
      • 4.2.1.2. Enteral administration
      • 4.2.1.3. Intravenous administration
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 4.3.1.2. U.S. Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 4.3.1.3. Canada Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 4.3.1.4. Canada Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 5.1. Europe Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Milk-Based
      • 5.1.1.2. Soy-Based
      • 5.1.1.3. Organic
      • 5.1.1.4. Probiotic/Prebiotic
  • 5.2. Europe Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Oral administration
      • 5.2.1.2. Enteral administration
      • 5.2.1.3. Intravenous administration
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.2. Germany Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.3. U.K. Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.4. U.K. Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.5. France Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.6. France Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.7. Italy Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.8. Italy Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.9. Turkey Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.10. Turkey Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.11. Russia Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.12. Russia Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.13. Rest of Europe Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.14. Rest of Europe Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 6.1. Asia Pacific Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Milk-Based
      • 6.1.1.2. Soy-Based
      • 6.1.1.3. Organic
      • 6.1.1.4. Probiotic/Prebiotic
  • 6.2. Asia Pacific Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Oral administration
      • 6.2.1.2. Enteral administration
      • 6.2.1.3. Intravenous administration
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.2. China Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.3. Japan Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.4. Japan Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.5. South Korea Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.6. South Korea Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.7. India Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.8. India Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.9. Southeast Asia Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.10. Southeast Asia Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.11. Rest of Asia Pacific Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.12. Rest of Asia Pacific Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 7.1. Latin America Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Milk-Based
      • 7.1.1.2. Soy-Based
      • 7.1.1.3. Organic
      • 7.1.1.4. Probiotic/Prebiotic
  • 7.2. Latin America Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Oral administration
      • 7.2.1.2. Enteral administration
      • 7.2.1.3. Intravenous administration
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.2. Brazil Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.3. Mexico Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.4. Mexico Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.5. Argentina Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.6. Argentina Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.7. Rest of Latin America Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.8. Rest of Latin America Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 8.1. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Milk-Based
      • 8.1.1.2. Soy-Based
      • 8.1.1.3. Organic
      • 8.1.1.4. Probiotic/Prebiotic
  • 8.2. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Oral administration
      • 8.2.1.2. Enteral administration
      • 8.2.1.3. Intravenous administration
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.2. GCC Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.3. South Africa Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.4. South Africa Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.5. Egypt Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.6. Egypt Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.7. Nigeria Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.8. Nigeria Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs by Route of Administration Heatmap
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Abbott Laboratories
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Baxter International Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Nestle S.A.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Danone
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Meiji Holdings Co., Ltd.,
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Fresenius SE & Co. KGaA
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Reckitt Benckiser Group Plc
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Perrigo Co. Plc
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Ingredion Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Solace Nutrition
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations